Pycnidione
Pycnidione is a natural small-molecule compound isolated from fungi. Pycnidione inhibits stromelysin/MMP3, targets cyclin D1/E, induces G1 phase arrest, modulates survivin, affects caspase-8/3, targets PAI-1, inhibits topoisomerases, and induces HIF-1α accumulation/nuclear translocation and DNA binding/reporter gene transactivation and erythropoietin expression. Pycnidione induces apoptosis, reactive oxygen species (ROS) generation, and mitochondrial membrane potential collapse. Pycnidione can be used for research on lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 149064-34-6
- Formula: C33H40O7
- Molecular Weight:548.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
|
stromelysin |
MMP3 |
Cyclin D1 |
cyclin E |
Survivin |
Caspase-8 |
Caspase-3 |
Topoisomerase |
PAI-1 |
HIF-1α |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
9.3 nM
|
Antiproliferative activity against human A549 non-small cell lung cancer cells assessed as 50% growth inhibition after 48 hrs by sulforhodamine B assay.
Antiproliferative activity against human A549 non-small cell lung cancer cells assessed as 50% growth inhibition after 48 hrs by sulforhodamine B assay.
|
22450442 |
| HT-1080 | GI50 |
55 nM
|
Antiproliferative activity against human HT-1080 fibrosarcoma cells assessed as 50% growth inhibition after 48 hrs by sulforhodamine B assay.
Antiproliferative activity against human HT-1080 fibrosarcoma cells assessed as 50% growth inhibition after 48 hrs by sulforhodamine B assay.
|
22450442 |
| SW1353 | GI50 |
893 nM
|
Antiproliferative activity against human SW1353 chondrosarcoma cells assessed as 50% growth inhibition after 48 hrs by sulforhodamine B assay.
Antiproliferative activity against human SW1353 chondrosarcoma cells assessed as 50% growth inhibition after 48 hrs by sulforhodamine B assay.
|
22450442 |
In Vitro
Pycnidione (48 h) inhibits proliferation of A549 human lung cancer cells with a GI50 of 9.3 nM, and also inhibits HT-1080 and SW1353 cells with GI50 values of 55 and 893 nM, respectively[1].
Pycnidione (3-100 nM; 6-48 h) up-regulates PAI-1 protein expression in A549 cells in a time- and concentration-dependent manner[1].
Pycnidione (30 nM; 24-72 h) induces G0/G1 cell cycle arrest and a subsequent sub-G1 apoptotic population increase in A549 human lung cancer cells[1].
Pycnidione (3-100 nM; 6-48 h) decreases cyclin D1 and cyclin E expression in A549 cells, with cyclin D1 reduction concentration-dependent at 3-100 nM and time-dependent decreases beginning at 12 h[1].
Pycnidione (3-100 nM; 6-48 h) down-regulates survivin and activates caspase-8 and caspase-3 in A549 cells, without affecting Bax expression[1].
Pycnidione (10-100 nM; 12-24 h) decreases mitochondrial membrane potential in A549 cells at 12 and 24 h[1].
Pycnidione (30-300 nM; 24 h) increases ROS generation in A549 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549 human lung cancer cells
-
Concentration:30 nM
-
Incubation Time:24, 48, and 72 h
-
Result:At 24 h, sub-G1 was 2.78%, G0/G1 was 65.78%, S was 3.08%, and G2/M was 28.53%.
At 48 h, sub-G1 was 4.87%, G0/G1 was 72.14%, S was 2.12%, and G2/M was 20.91%.
At 72 h, sub-G1 was 20.47%, G0/G1 was 58.05%, S was 3.08%, and G2/M was 18.53%.
Induced a time-dependent increase in G1 phase arrest and a subsequent increase in the hypodiploid sub-G1 phase population.
-
Cell Line:A549 human lung cancer cells
-
Concentration:100 nM (6, 12, 24, 48 h); 3, 10, 30, and 100 nM (24 h)
-
Incubation Time:6, 12, 24, and 48 h; 24 h
-
Result:At 100 nM, pycnidione induced a time-related decrease in cyclin D1 and cyclin E protein levels compared to controls; levels started to decrease 12 h after exposure.
At 24 h, 3, 10, 30, and 100 nM pycnidione decreased cyclin D1 expression in a concentration-dependent manner.
After 24 h, pycnidione demonstrated no significant effects on p21 expression; at 48 h, partial attenuation of p21 expression was observed compared to controls.\nExerted time-dependent inhibition of survivin expression.
At 24 h, 3, 10, 30, and 100 nM pycnidione resulted in a concentration-dependent reduction in survivin protein expression compared with controls.
Sequentially induced the proteolytic cleavage of inactive procaspase-8 and -3.
Did not affect Bax protein expression.\nPAI-1 protein was constitutively expressed in A549 cells.
At 100 nM, pycnidione gradually and significantly enhanced PAI-1 protein levels by 1.42-, 1.55-, and 1.57-fold at 6, 12, and 24 h in comparison to controls.
Chemical Information
-
CAS No. 149064-34-6
-
Molecular Weight 548.67
-
Formula C33H40O7
-
SMILES
C[C@@]12[C@](CC(C)(/C=C\C[C@]3([C@](CC4=C(C=C(C(C=C4C)=O)O)O3)([H])C[C@H]2O)C)C)([H])CC5=C(C=C(C(C=C5C)=O)O)O1
-
Structure Classification
-
Initial Source
Phoma sp.
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Protocol for Electrophoretic Mobility Shift Assay (EMSA)
Electrophoretic mobility shift assay detects protein-nucleic acid binding by incubating a labeled DNA or RNA probe with purified protein or cell extract, then separating free probe from slower-migrating protein-probe complexes on a native gel. For cancer cells, primary neurons, mouse tumor samples, intestinal organoids, inflammatory macrophages, or drug-treated samples, EMSA can measure transcription-factor DNA binding or RNA-binding protein activity in extracts, but it does not directly measure transcription, protein expression, or chromatin occupancy in intact cells. Specificity is judged by competition with unlabeled wild-type probe, failure of mutated or unrelated competitors to compete, and antibody supershift or disruption when the binding protein identity must be confirmed.
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)